Myasthenia Gravis Foundation of America (MGFA) Scientific Session @checkrare
Myasthenia Gravis Foundation of America (MGFA) Scientific Session  @checkrare
Uploaded September 2026 | Updated November 2026, 2 days ago
Jenny McCue, Vice President of Global Research and Clinical Development at the Myasthenia Gravis Foundation of America (MGFA), discusses research highlights to be presented at the upcoming 2026 MGFA Scientific Session being held September 29th in Orlando, FL.
Myasthenia Gravis Foundation of America (MGFA) Scientific SessionAlexander Disease and the Approval of Zanvastro (Zilganersen)Topline Results From the SANRECO Trial Testing Divesiran in Polycythemia VeraNew Treatment Option for Recurrent Respiratory Papillomatosis3D Printed Treatment Options | The CheckRare BriefResults From the PROGRESS Study of Zilurgisertib in Patients With FOPPhase 3 OASIS Study Shows Promise of Oral Olorofim for Invasive AspergillosisNew Stem Cell Method Could Advance Research Into Spinal Muscular AtrophyInterim PHINDER Analyses in Interstitial Lung DiseaseCh 3: VALIANT Results on the Longer-Term Impact of EmpaveliFDA Approves New Therapies for MPS IIIA and SMA | The CheckRare Brief Ep 8Fabry Disease: Patients Real-World Problems and How to Manage Them
CheckRare |

Myasthenia Gravis Foundation of America (MGFA) Scientific Session

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER